Fresenius | FRE - Selling And Administration Expenses


Fresenius reported EUR819M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 901M 36M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.21B 13M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Beiersdorf EUR 271M 51M Dec/2025
DaVita Healthcare Partners USD 472.36M 57.99M Dec/2025
Demant DKK 6.09B 135M Dec/2025
E.ON EUR -1.71B 3.63B Jun/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Getinge SEK 2.65B 452M Dec/2024
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GN Store Nord DKK 1.45B 41M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
RWE EUR 690M 84M Mar/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025